After a case-mix adjustment, hospitals that are smaller, have higher annual ischemic stroke admission volume and are located in rural settings are more likely to have patients spend time at home within 90 days of suffering an ischemic stroke,…

Medicare beneficiaries with nonvalvular atrial fibrillation who received 20 mg per day of rivaroxaban had statistically significant increases in intracranial hemorrhage and major extracranial bleeding compared with those who received 150 mg of…

A single-arm study found that all of the patients with moderate or severely calcified peripheral lesions who received the lithoplasty system achieved the primary efficacy endpoint of procedural success.

The researchers defined procedural…

The FDA cleared the TrailBlazer angled support catheter on Sept. 23 for use in the peripheral vascular system.

The catheter, which is manufactured by Medtronic,…

After a stroke, patients often lose muscle strength and require upper limb rehabilitation. Still, the best way to help patients recover depends on how long ago they had their stroke and on other factors.

A recent study suggests that…

Medtronic announced new data, demonstrating safety and efficacy at three years in acute complicated Type B aortic dissection patients treated with the Valiant Captivia Thoracic Stent Graft System. Ali Azizzadeh, MD, FACS, University of Texas…

Women who experience menopause earlier are at greater risk for cardiovascular issues such as heart disease and stroke and even have greater all-cause mortality rates than women who experience menopause nearer the average age of 51, according to a…

The FDA cleared Shockwave Medical’s lithoplasty system Sept. 16 to treat calcified plaque in patients with peripheral artery disease.

The system combines a angioplasty balloon catheter device and sound waves known as lithotripsy, which…

Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty System for the treatment of calcified plaque in patients with…

Adults with chronic hand impairment after suffering a stroke improved their manual dexterity when they received 12 weeks of contralaterally controlled functional electrical stimulation (CCFES).

The benefits of CCFES were superior to…

Hypertension increases risk for heart disease and stroke, yet it is characterized by subtle symptoms that often go undetected. Lifestyle factors—such as diet and exercise—are thoughts to contribute to a patient’s risk of developing high blood…

More than three million people in the U.S. each year are diagnosed with anemia. Previous research has shown that the condition is independently associated with increased mortality in patients with chronic kidney disease, heart failure and acute…

Baxter International, Inc. recently alerted the FDA of multiple adverse events associated with the company’s Vascu-Guard peripheral vascular patch, which is used during carotid endarterectomy.

The FDA…

New uses for two stroke therapy devices were approved by the FDA Sept. 2, according to a …

As the opioid epidemic continues to put users at risk for serious conditions and diseases, new research that shows injection opioid drug use is related to life-threatening heart infections has experts posing solutions to the growing drug problem…

The Centers for Medicare & Medicaid Services (CMS) approved the left atrial appendage (LAA) occlusion registry on Aug. 17 to…

Patients who had acute major bleeding associated with factor Xa inhibitors experienced a significant reversal of anti-factor Xa activity when they received an andexanet bolus and infusion, according to a multicenter, open-label trial.

Lead…

Stents have long been the preferred treatment for reopening blocked arteries in patients who’ve suffered a heart attack or other heart conditions. But new research suggests that physicians may be able to forgo stent procedures and instead give…

Patients with anemia had an increased risk of death up to one year after suffering a stroke, according to a meta-analysis in the U.K.

Lead researcher Raphae S. Barlas, MA, of the Institute of Applied Health Sciences in Aberdeen, U.K., and…

After searching for more than eight months for a new CEO, Cardiovascular Systems ended up choosing an employee of its own to permanently take over the position effective immediately.

Scott Ward, 56, who has been serving as the company’s…

More than 90 percent of patients with symptomatic peripheral artery disease (PAD) did not have major adverse events within 30 days of undergoing endovascular procedures with the Diamondback 360 peripheral orbital atherectomy system and other…